Literature DB >> 19775296

Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.

Pieter Van Vlierberghe1, An De Weer, Pieter Mestdagh, Tom Feys, Katleen De Preter, Pascale De Paepe, Kathleen Lambein, Jo Vandesompele, Nadine Van Roy, Bruno Verhasselt, Bruce Poppe, Frank Speleman.   

Abstract

Classical Hodgkin lymphoma (cHL) is characterized by the presence of malignant Hodgkin and Reed Sternberg (HRS) cells. The scarcity of tumour cells in lymphoma biopsies has hampered genetic analyses of HRS cells, including microRNA (miRNA) expression profiling. We determined the expression of 360 miRNAs in microdissected HRS cells from nine cHL patients. These miRNA profiles were compared to those from four cHL cell lines and CD77+ B-cells, yielding a distinct cHL signature of 12 over- and three underexpressed miRNAs. Our data suggest that miRNAs are implicated in the pathogenesis of Hodgkin lymphoma and prompt further investigations concerning their role in cHL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19775296     DOI: 10.1111/j.1365-2141.2009.07909.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

Review 2.  Hodgkin lymphoma.

Authors:  Ralf Küppers; Andreas Engert; Martin-Leo Hansmann
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

3.  Circulating microRNAs involved in multiple sclerosis.

Authors:  Sue Rutherford Siegel; Jason Mackenzie; George Chaplin; Nina G Jablonski; Lyn Griffiths
Journal:  Mol Biol Rep       Date:  2012-01-10       Impact factor: 2.316

4.  Transcriptome dynamics of the microRNA inhibition response.

Authors:  Jiayu Wen; Eleonora Leucci; Roberto Vendramin; Sakari Kauppinen; Anders H Lund; Anders Krogh; Brian J Parker
Journal:  Nucleic Acids Res       Date:  2015-06-18       Impact factor: 16.971

5.  Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.

Authors:  Semra Paydas; Arbil Acikalin; Melek Ergin; Hikmet Celik; Basak Yavuz; Kahraman Tanriverdi
Journal:  Med Oncol       Date:  2016-03-07       Impact factor: 3.064

Review 6.  Relevance of miR-21 in HIV and non-HIV-related lymphomas.

Authors:  Durairaj Sekar; Villianur Ibrahim Hairul Islam; Krishnaraj Thirugnanasambantham; Subramanian Saravanan
Journal:  Tumour Biol       Date:  2014-06-25

7.  MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.

Authors:  Beatriz Sánchez-Espiridión; Ana M Martín-Moreno; Carlos Montalbán; Vianihuini Figueroa; Francisco Vega; Anas Younes; L Jeffrey Medeiros; Francisco J Alvés; Miguel Canales; Mónica Estévez; Javier Menarguez; Pilar Sabín; María C Ruiz-Marcellán; Andrés Lopez; Pedro Sánchez-Godoy; Fernando Burgos; Carlos Santonja; José L López; Miguel A Piris; Juan F Garcia
Journal:  Br J Haematol       Date:  2013-06-01       Impact factor: 6.998

8.  Micro-RNA Expression and Function in Lymphomas.

Authors:  Sukhinder K Sandhu; Carlo M Croce; Ramiro Garzon
Journal:  Adv Hematol       Date:  2011-03-22

9.  Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.

Authors:  Diponkar Banerjee
Journal:  Adv Hematol       Date:  2011-01-18

10.  MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients.

Authors:  Alfons Navarro; Carmen Muñoz; Anna Gaya; Marina Díaz-Beyá; Bernat Gel; Rut Tejero; Tania Díaz; Antonio Martinez; Mariano Monzó
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.